Human-Gyrovirus-Apoptin Triggers Mitochondrial Death Pathway—Nur77 is Required for Apoptosis Triggering  by Chaabane, Wiem et al.
www.neoplasia.com
Volume 16 Number 9 September 2014 pp. 679–693 679Human-Gyrovirus-Apoptin
Triggers Mitochondrial Death
Pathway—Nur77 is Required for
Apoptosis TriggeringWiem Chaabane*,†, Artur Cieślar-Pobuda*,‡,
Mohamed El-Gazzah†, Mayur V. Jain*,
Joanna Rzeszowska-Wolny‡, Mehrdad Rafat&,
Joerg Stetefeld§, Saeid Ghavami¶ andMarek J. Łos*,#
*Department of Clinical and Experimental Medicine (IKE),
Division ofCell Biology, and Integrative RegenerativeMedicine
Center (IGEN), Linköping University, Linköping Sweden;
†Department of Biology, Faculty of Sciences, Tunis University,
Tunis, Tunisia; ‡Inst. of Automatic Control, Silesian Univ. of
Technology, Gliwice, Poland; §Department of Chemistry,
University of Manitoba, Winnipeg, Canada; ¶Department of
Human Anatomy and Cell Science, University of Manitoba,
Winnipeg, Canada; #Department of Pathology, Pomeranian
Medical University, Szczecin, Poland; &Department of
Biomedical Engineering, Linköping University, Linköping Sweden.Abstract
The human gyrovirus derived protein Apoptin (HGV-Apoptin) a homologue of the chicken anemia virus Apoptin
(CAV-Apoptin), a protein with high cancer cells selective toxicity, triggers apoptosis selectively in cancer cells. In
this paper, we show that HGV-Apoptin acts independently from the death receptor pathway as it induces apoptosis in
similar rates in Jurkat cells deficient in either FADD (fas-associated death domain) function or caspase-8 (key players of
the extrinsic pathway) and their parental clones. HGV-Apoptin induces apoptosis via the activation of themitochondrial
intrinsic pathway. It induces both mitochondrial inner and outer membrane permebilization, characterized by the loss
of the mitochondrial potential and the release into cytoplasm of the pro-apoptotic molecules including apoptosis
inducing factor and cytochrome c. HGV-Apoptin acts via the apoptosome, as lack of expression of apoptotic protease-
activating factor 1 in murine embryonic fibroblast strongly protected the cells from HGV-Apoptin–induced apoptosis.
Moreover, QVD-oph a broad-spectrum caspase inhibitor delayed HGV-Apoptin–induced death. On the other hand,
overexpression of the anti-apoptotic BCL-XL confers resistance to HGV-Apoptin–induced cell death. In contrast, cells
that lack the expression of the pro-apoptotic BAX and BAK are protected from HGV-Apoptin induced apoptosis.
Furthermore, HGV-Apoptin acts independently from p53 signal but triggers the cytoplasmic translocation of Nur77.
Taking together these data indicate that HGV-Apoptin acts through the mitochondrial pathway, in a caspase-
dependent manner but independently from the death receptor pathway.
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Apoptosis is the process whereby individual cells of multicellular
organisms undergo systematic self-destruction in response to a wide
variety of stimuli [1]. Apoptosis is a genetically encoded program that
is involved in normal development and homeostasis and in diverse
patho-physiological processes [2]. Apoptosis functions to eliminate
cells during development when they become redundant or as an
emergency response after radiation damage, viral infection, or
aberrant growth induced by the activation of oncogenes [1]. The
morphology of apoptosis is orchestrated by the proteolytic activity of
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proteins largely orchestrate apoptotic process [6]. In vertebrate cells,
apoptosis typically occurs through one of two the major signaling
pathways termed the extrinsic/cell death receptor pathway and the
intrinsic/mitochondrial-initiator pathway [7]. In the extrinsic
pathway, the ligation of the death receptors leads to the recruitment
of the adaptor molecule FADD (fas-associated death domain) that
bind, trimerize, and activate an initiator caspase (caspase-8), that in
turn directly cleaves and activates the apoptosis executioner caspases
(caspase-3 and -7) [2,7,8]. In the intrinsic pathway, the mitochondria
responds to apoptotic stimuli through mitochondrial outer mem-
brane permeabilization (MOMP). MOMP leads to the release of pro-
apoptotic proteins from the mitochondrial intermembrane space.
Following its release, cytochrome c (cyt c) binds apoptotic protease-
activating factor 1 (APAF1), inducing its conformational change and
oligomerization and leading to the formation of a caspase activation
platform termed apoptosome. The apoptosome recruits, dimerizes,
and activates an initiator caspase, caspase-9, which, in turn, cleaves
and activates caspase-3 and -7 [2,7,8]. Thus the caspase cascade
activation result from the remarkable MOMP and its subsequent
intermembrane space mitochondrial proteins release. MOMP is
highly regulated by the B cell lymphoma 2 (BCL-2) family members
[2] which have been classified into 3 classes [9,10]. One class inhibits
apoptosis (BCL-2, BCL-XL, MCL-1, etc), the second class promotes
apoptosis (BAX, BAK), and a third class termed the BH3-only proteins
(BAD, BIK, BID, BIM, BOK, etc.) binds and regulates the anti-
apoptotic BCL-2 proteins to promote apoptosis [4]. While the pro-
apoptotic family members BAX and BAK are crucial for the induction
of MOMP and the release of the pro-apoptotic molecules, the anti-
apoptotic family members BCL-2 and BCL-XL inhibit BAX and
BAK [4,11]. Following MOMP, the mitochondrial transmembrane
potential is dissipated through caspase-dependent and caspase-
independent means [2,12,13]. The intrinsic death pathway is
induced by many different stress signals including DNA-damaging
agents, viral and cellular oncogenes, and transcriptional blockade
[12,14]. The stimuli are transmitted from the nucleus to the
mitochondria by two main molecules: the tumor suppressor gene p53
and the orphan steroid receptor Nur77 [15].
Apoptosis plays an important role in the treatment of cancer as it is
induced bymany treatments [16].While the most used strategies aim at
targeting the apoptotic defects [16], some of the emerging strategies aim
at the development of cancer selective therapies by molecules that target
and kill preferentially cancer cells. One of the potential tools for cancer
selective therapy is CAV-Apoptin as it induces apoptosis selectively in
cancer cells [17,18]. CAV-Apoptin is a viral protein of 14 kDa derived
from the chicken anemia virus [19,20]. The selective toxicity of CAV-
Apoptin is associated at least in part to its tumor specific nuclear
localization and its tumor specific phosphorylation at Theorine-108,
which are essential for its nuclear accumulation and its induction of
apoptosis [21,22]. Recently, the human homolog of theCAVnamed the
human gyrovirus (HGV) has been identified [23]. Its genome presents
an overall organization similar to that of CAV [23,24], it consists of a
single negative-strand circular DNA of 2315 nucleotides. HGV has a
similar organization of the promoter region and the encoded proteins as
the CAV as revealed by both virus sequence alignment. It encodes a 125
amino-acid homologue of the CAV-Apoptin VP3 protein that despite a
low overall identity has conserved important sites including nuclear
localization and export signals and phosphorylation sites [23,25]. HGV-
Apoptin has the same subcellular distribution as the CAV-Apoptin, itlocalizes in the nuclei of cancer cells where it shows a granular
distribution that later clusters to form aggregates while it remains in the
cytoplasm of normal human cells [25]. Like CAV-Apoptin, HGV-
Apoptin induces apoptosis selectively in cancer cells but not in normal
cells [25] and is therefore a potential biologics anti-tumor candidate.
In this paper, we focus on the molecular mechanisms of HGV-
Apoptin selective toxicity. Using cells with defective FADD or
caspase-8 (key players in death receptor signaling), APAF1 deficient
cells, BAK/BAX-deficient cells, and other molecular tools, we
demonstrate that HGV-Apoptin induces apoptosis independently
of the death receptor pathway. Hence, it triggers the activation of the
mitochondrial death pathway via MOMP and the release of cyt c, and
apoptosis-inducing factor (AIF) from mitochondria, in a caspase
dependent manner. HGV-Apoptin induced apoptosis is modulated
by the BCL-2 family members, is independent from p53 signal and
causes the cytoplasmic translocation of Nur77.
Material and Methods
Chemotherapeutics Inhibitors
Staurosporine (2.5 μM) was purchased from Roche Diagnostics,
Mannheim, Germany. The broad-range caspase inhibitor QVD-OPh
was from Enzyme Systems (Dublin, CA, USA) and was added to the
cells at a concentration of 25 μM immediately after transfection.
Antibodies
The following primary antibodies were used: mouse anti-active
caspase-8 (Cell Signaling Technology, Beverly, USA), rabbit anti
FAS, and anti FADD antibodies (Santa Cruz Biotechnology), murine
activating anti-CD95/FAS (50 ng/ml) from upstate signaling, rabbit
anti-AIF IgG (Sigma-Aldrich), mouse anti-p53 antibody (Millipore),
Rabbit anti-Flag (Thermo/Fisher Scientific), rabbit anti-nur77 IgG
(Santa Cruz), mouse anti–β-actin (Abcam). The following secondary
antibodies were used: Infrared dye 800cw goat, anti-rabbit antibody,
Infrared dye 680cw goat, anti-mouse antibody (Licor), Rhodamine
redX anti-rabbit antibody (Life Technologies), cy5 anti-murine
antibody (Abcam).
Cell Culture and Reagents
Jurkat (T-cell leukaemia) cells, Jurkat clones stably transfected with
FADD-DN (a dominant-negative FADDmutant lacking theN-terminal
death-effector domain), caspase-8 deficient Jurkat cells, Jurkat cells
overexpressing BCL-XL and MCF7 (breast adenocarcinoma), MCF7
expressing caspase-3, MCF7 overexpressing BCL-XL cells, and MCF7
expressing GFP–cyt c were grown in RPMI-1640 medium supple-
mented with 10% fetal calf serum (Hyclone), 100 μg/ml penicillin and
0.1 μg/ml streptomycin (Gibco BRL). HCT116 (colon carcinoma),
MEF (mouse embryonic fibroblasts) immortalized by retroviral
transduction with a temperature-sensitive simian virus 40 large T antigen
as described in [26], MEF-APAF1–/–, and MEF-BAX-BAK–/– were
grown in DMEM medium supplemented with 10% fetal calf serum
(Hyclone), 100 μg/ml penicillin and 0.1 μg/ml streptomycin (Gibco
BRL). Human primary fibroblasts were grown in FibroGRO media for
culture of human fibroblast (Millipore). Cells were grown at 37 °C with
5% CO2 in a humidified incubator.
Plasmids and Transient Transfections
The expression vectors of HGV-Apoptin GFP-HGV-APT and
FLAG- HGV-APT were provided by Dr M. Tavassoli [25]. The
empty vector pEGFPC1 was used as negative control. Cells were
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according to the manufacturer's instructions (Roche), Jurkat cells
were transfected by electroporation using a BIO-RAD electroporator
at a density of 107 cells per electroporation with 60 μg of DNA. The
expression of GFP and GFP-HGV-Apoptin was confirmed by
fluorescence microscopy. The broad-range caspase inhibitor QVD-
oph was added to the cells at a concentration of 25 μM immediately
after transfection.
Measurement of Apoptosis by Flow Cytometry
Apoptosis was quantified at the indicated time points after
transfection using PO-PRO and 7-amino-actinomycin D (7AAD)
staining and according to the manufacture's instructions (Invitrogen).
Briefly, at the indicated time points, cells were harvested and washed
twice with PBS, then stained in PBS with PO-PRO and 7AAD for
30 min on ice. Cells were analysed using a Gallios flow-cytometer.
The population, of GFP positive cells that corresponds to the cells
transfected with either the control vector pEGFPC1 or with GFP-
HGV-APT were gated and analyzed among the whole population of
cells, by staining cells with PO-PRO™-1 and 7-AAD apoptotic cells
show violet/blue fluorescence, dead cells show violet/blue and red
fluorescence, and live cells show little or no fluorescence.
Measurement of Mitochondrial Membrane Potential
Mitochondrial permeability transition was determined by staining
the cells with tetramethylrhodamine methyl ester (TMRM) (Life
Technologies). The cells were harvested and washed once with PBS
then stained with TMRM 15 min at 37 °C and mitochondrial
membrane potential was quantified by flow cytometric determination
of the FL2 fluorescence of the cells. Data were collected and analyzed
using a flow analysis Beckman-Coulter software (Kaluza).
Immunocytochemistry and Confocal Imaging
Cells were grown overnight on coverslips and then transfected with
pEGFPC1, FLAG, GFP-HGV-APT, and FLAG-HGV-APT. After the
indicated time points, cells were washed with PBS and then fixed in 4%
paraformaldehyde for 20 min then permeabilized with 0.1% Triton X-
100 and blocked in 0.1% BSA. To detect AIF release, cells were
incubated with anti-AIF rabbit IgG (Sigma-Aldrich); diluted 1:500.
Followed by three wash steps with PBS, the anti-AIF-antibody
complexes were stained with the corresponding Rhodamine redX
secondary antibody (diluted 1:200) then washed 3 times with PBS. To
visualize nuclei, cells were stained withDAPI (10 μg/ml). The samewas
done for Nur77 using anti-Nur77 rabbit IgG (Santa-Cruz). The
fluorescent images were then observed and analyzed with a Zeiss LSM
510 inverted laser-scanning confocal fluorescencemicroscope using 63×
(NA 5 1.4) oil planochromat objective (Carl Zeiss, Thornwood, NY).
Cell Extracts and Immunoblotting
The activation of caspase8 and the level of protein expression of Fas
and FADD, were detected by immunoblotting. Briefly, 2×105 cells
were transfected with pEGFPC1 vector alone or with GFP-HGV-
APT. The expression of GFP and GFP-HGV-APT was confirmed by
fluorescence microscopy. At the indicated time periods green cells
were sorted using BD FACSAria III cell sorter (Becton Dickinson,
Palo Alto CA, USA), whole cell lysates were prepared from green
fluorescent cells using RIPA Buffer and according to the manufac-
ture's instructions (Thermo-Scientific). Proteins (30 μg) were
separated by denaturing SDS-PAGE and then transferred onto a
PVDF membrane. The membranes were blocked in 5% non-fat drymilk in TBS 0.1% Tween and then incubated overnight with the
following primary antibodies: anti-active caspase8 (Cell Signaling
Technology, Beverly, USA), anti FAS, and anti FADD antibodies
(Santa Cruz Biotechnology, Inc.) at 4 °C. Then, the blots were
incubated with the corresponding InfraRed dye secondary antibodies
(Licor). The visualization of the membrane was carried using Licor
membrane scanner.
Detection and Quantification of Apoptotic Cells Using Laser
Scanning Cytometry
Cells grown on cover slips and transfected with pEGFPC1 control
vector or GFP- HGV-APT were stained at the indicated time points
post-transfection with DAPI and then analysed by Laser scanning
cytometry, using the one primary (DAPI fluorescence) and one sub
(GFP fluorescence) protocol. For the detection of the chromatin
condensation, three parameters were used, the nuclear area, the green
maxpixel, and the blue maxpixel values. In this case, the nuclear area
was set on the blue channel, cells with high blue maxpixel values
(condensed chromatin) [27] are considered apoptotic.
Results
HGV-Apoptin Induce Apoptosis Independently from the Death
Receptor Pathway
Both CD95 ligand and its receptor are rapidly expressed following
T cell activation. In both cases, the soluble CD95L can act either in an
autocrine manner and trigger apoptosis at a single cell level or can also
mediate at high concentrations apoptosis of short distanced neighboring
cells in a paracrinemanner. CD95L can also act at themembrane bound
form and also trigger apoptosis in an autocrine/paracrine manner.
To examine the role of the CD95 system in HGV-Apoptin
induced apoptosis, we have tested the role of components of the
death-inducing signal complex (DISC) which is critical for initiation
of death-receptor-mediated apoptosis [28]. DISC is a complex of
proteins formed upon the recruitment of the initiator caspase, pro-
caspase-8, through its pro-domain together with FADD, a bipartite
molecule with a death effector domain, to the death receptor [28–30].
This leads to the activation of the initiator caspase-8 that will directly
mediate the down-stream caspase cascade and the execution of
apoptosis through the death receptor pathway [30,31].
First, we have tested the role of caspase-8 using Jurkat T cells that
lacked the expression of caspase-8 (Jurkat-caspase-8−/−). Transiently
expressed HGV-Apoptin in these cells accumulates in the nucleus
similar to that of their wild type counterparts, and induces apoptotic
morphological changes including cell contraction and nuclear conden-
sation (Figure 1A). Thus, suggesting that the lack of caspase-8 does not
affect the ability of HGV-Apoptin to induce apoptosis in Jurkat cells.
To further confirm the above findings, caspase-8 activation was
monitored byWestern blot of the cell lysates fromGFP-positiveMCF7
and HCT116 at the indicated time points post-transfection with GFP-
HGV-Apoptin and its corresponding pEGFPC1 control vector. Up to
72 hours post-transfection, caspase-8 activation was not detected in
both cell lines in response to HGV-Apoptin transient expression unlike
the cells that were treated with anti-FAS antibody or daunorubucin or
both activators of the death receptor pathway and caspase-8 (Figure 1B).
Taking together this data show that caspase-8 is neither required nor
activated during HGV-Apoptin induced apoptosis.
Next, we tested the role of the FADD adaptor molecule in HGV-
Apoptin triggered apoptosis in Jurkat T cells that are overexpressing a
truncated, dominant-negative form of FADD (FADD-DN). The
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Figure 1. HGV-Apoptinmediated cell death is independent of the death receptor pathway. A) Cellular localization andmorphological changes
induced by HGV-Apoptin in Jurakt WT or Jurkat caspase-8-/- cells. Cells were transfected by electroporation with GFP-HGV-APT and the
corresponding pEGFPC1 control plasmid, cells were fixed 48 h post transfection and stained with DAPI for the detection of nuclear
morphology. B) HGV-Apoptin does not activate caspase-8. Western blot analysis of cell lysates from HCT116 (colon carcinoma) and MCF7
cells transfected either with pEGFPC1 or with GFP-HGV-APT for caspase-8 activation. At the indicated time points post-transfection, GFP
positive cells were sorted by flow cytometry; cells treated with anti-FAS activating antibodies, or, Daunorubicin or both represent a positive
control. C) Detection of apoptosis induced by HGV-Apoptin in Jurkat WT cells or Jurkat FADD-DN. Cells were transfected by electroporation
with GFP-HGV-APT or the corresponding pEGFPC1 control plasmid. 48 h later, transfected Jurkat cells were fixed and stained with DAPI for
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and cell death was measured by flow cytometry after 12 h. F) Western blot analysis of FAS and FADD level of expression in Jurkat cells 48 h
post transfection with GFP-HGV-APT or the corresponding pEGFPC1 control vector. In panels “B” and “F” β − actin was used as a protein
loading control. G) Quantification of the level of expression of FAS and FADD 48 h post-transfection (Western blot shown in “G”).
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Figure 1. (continued).
Neoplasia Vol. 16, No. 9, 2014 Human-Gyrovirus-apoptin action Chaabane et al. 683expression of a dominant negative form of FADD prevents the
formation of a functional DISC and will block the signaling via the
extrinsic pathway. Jurkat-FADD-DN cells show apoptotic morphol-
ogy similar to the Jurkat WT cells (Jurkat expressing the intact
DADD) after transient expression of HGV-Apoptin (Figure 1C).
Moreover the monitoring of apoptosis induced by HGV-Apoptin in
both Jurkat-WT and Jurkat-FADD-DN cells from 24 to 120 hourspost-transfection by flow cytometry shows that both WT and FADD-
DN cells have similar sensitivity to HGV-Apoptin (Figure 1D). Thus,
the state of FADD has no effect in HGV-Apoptin induced apoptosis.
In a control experiment, Jurkat WT and FADD-DN were treated
for 12 hours with the anti-FAS human activating antibody, which
induce cell death via the recruitment of FADD and the activation of
caspase-8. After 12 hours of treatment, while almost all the Jurkat
684 Human-Gyrovirus-apoptin action Chaabane et al. Neoplasia Vol. 16, No. 9, 2014WT cells were dead, the Jurkat-FADD-DN were completely resistant
to treatment with FAS (Figure 1E).
The above observations were further confirmed by monitoring the
expression of FAS and FADD in GFP-HGV-Apoptin transiently
expressing Jurkat cells by Western blot. The protein expression
profiles of these apoptotic regulators were monitored in cell lysates of
the GFP-positive cells at 48 h post-transfection. Expression of FAS
and FADD were detected in all the samples with no significant
increase in response to HGV-Apoptin expression. (Figure 1, F and G)
Taking together this data indicates that HGV-Apoptin similar to its
homolog CAV-Apoptin induce apoptosis independently from the
death receptor pathway.
HGV-Apoptin Triggers theMitochondrial Pathway of Cell Death
and Induces Mitochondrial Alterations
To gain more insight into the mechanism of apoptotic signaling
triggered by HGV-Apoptin, we investigated the role of the
mitochondrial intrinsic pathway in HGV-Apoptin induced apopto-
sis. The intrinsic signaling pathways that initiate apoptosis involve
diverse non-receptor mediated stimuli that produce intracellular
signals. These signals act directly on targets within the cell and are
mitochondrial-initiated events [32] that lead to mitochondrial
alterations and loss of the mitochondrial membrane potential [33].
Thus in order to assess changes in the mitochondrial potential
induced by HGV-Apoptin we have used the TMRM dye that is
rapidly sequestrated by healthy mitochondria while the depolarizedB
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HCT116 shows a huge decrease in the mitochondrial potential
among HGV-Apoptin transient expressing cells (Figure 2B). Similar
results were obtained in Jurkat WT cells along with the mutant
Jurkat FADD-DN cells after transfection with HGV-Apoptin
showing that FADD have no effect on the loss of the mitochondrial
potential caused by HGV-Apoptin (Figure 2C). This data indicates
that HGV-Apoptin triggered apoptosis is associated with the loss of
the mitochondrial potential and further confirms that this occurs
independently from the death receptor pathway.
HGV-Apoptin Induces the Release of the Mitochondrial
Components Cytochrome c and AIF and Triggers the
Apoptosome Pathway
Most pro-apoptotic stimuli that involve mitochondrial outer
membrane permeabilization leading to intra-cytosolic release of
mitochondria intermembrane space proteins such as cytochrome c
(cyt c) will trigger caspase activation and/or AIF mediated caspase
independent death pathway [35]. Activation of both pathways often
coexists. Thus to further examine the effect of HGV-Apoptin on
mitochondria, we have first checked cyt c release. For that purpose we
have used MCF7 cells stably transfected with GFP–cyt c fusion
protein (MCF7-cytc-GFP). As shown in Figure 3A, the transientC
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release of cyt c into the cytoplasm but not the transient expression of
the FLAG empty vector (please note the selective loss of the green
granular pattern in cells transfected with FLAG-HGV-APT).
Next, we checked for the release of AIF. Similar to cyt c release, the
release of AIF from mitochondria was also detected by confocal
microscopy in HCT116 in response to GFP-HGV-Apoptin transient
expression (Figure 3B). This data show that HGV-Apoptin triggers
the release of the mitochondrial components cyt c and AIF.
While AIF can cause apoptosis through high molecular weight
DNA fragmentation and chromation condensation independently
from caspase activity [35,36], cyt c, along with dATP binds APAF1
and form the death signaling platform: apoptosome. This event is a
key step for caspase-9 activation and is crucial for the initiation of
apoptosis via the intrinsic pathway [37]. Therefore, in order to give
more insight into the role of the apoptosome in HGV-Apoptin
induced cell death we have checked the role of APAF1 using
transformed mouse embryonic fibroblast genetically modified to
lack the expression of APAF1 in transformed mouse embryonic
fibroblast (MEF-APAF1−/−). Expression of GFP-HGV-Apoptin
in MEF-APAF1−/−is non-toxic as compared to the WT cells
(Figure 4, A and B). These results show that HGV-Apoptin induce
apoptosis via the apoptosome and further confirm the implication of the
mitochondrial intrinsic pathway in HGV-Apoptin induced apoptosis.
HGV-Apoptin Mediated Cell Death is Caspase Dependent
To further elucidate the HGV-Apoptin triggered death pathway,
we have checked the role of caspases, the key mediator of the
apoptotic program [5]. Upon apoptosis triggering, the upstream
caspases (caspase-8, caspase-9) cleave and activate downstream
caspases (caspase-3, caspase-7) leading to the execution of apoptosis.
For this purpose, Jurkat T cells were transfected with GFP-HGV-
APT in the presence or the absence of 25 μM of the broad-range
caspase inhibitor (QVD-oph). At 24 hours post-electroporation cells
were examined microscopically for protein expression and the effects
of QVD-oph. In the presence of QVD-oph, cells that express HGV-
Apoptin were partially protected from cell death. In contrast, QVD-
oph non-treated cells were highly sensitivity to HGV-Apoptin. To
investigate the effect of caspase inhibition in detail, apoptosis was
monitored in both Jurkat non-treated cells and Jurkat cells treated
with caspase inhibitor QVD-oph from 24 to 120 h post-transfection.
As shown in Figure 5A, the inhibition of caspase activity by QVD-
oph delayed HGV-Apoptin induced apoptosis in Jurkat cells.
To further investigate whether the inhibition of caspase could
block HGV-Apoptin induced apoptosis, cell death was monitored
among caspase-3-deficient MCF7 cells and MCF7 cells stably
overexpressing caspase-3 (MCF7/C3) either left untreated or treated
with 25 μM of the caspase inhibitor QVD. As shown in Figure 5B,
the ectopic expression of caspase-3 renders MCF7 more sensitivity to
HGV-Apoptin. Moreover, treatment with the caspase inhibitor
QVD-oph strongly inhibited HGV-Apoptin induced apoptosis in
both MCF7 and MCF7/C3 cells, these results further confirm that
caspase activity is required for HGV-Apoptin induced apoptosis.
HGV-Apoptin Mediated Cell Death is Modulated by the BCL-2
Family Members
Mitochondrial outer membrane permeabilization, which plays a
crucial role in apoptosis induction, is controlled by pro- and anti-
apoptotic members of the BCL-2 family [35]. Therefore we examinedthe role of both pro- and anti-apoptotic BCL-2 family in HGV-
Apoptin induced apoptosis. First we checked the role of the anti-
apoptotic BCL-XL in HGV-Apoptin induced cell death. We
compared the sensitivity towards HGV-Apoptin induced apoptosis
between the parental MCF7 cell line and its derivates stably over-
expressing BCL-XL. The transient expression of HGV-Apoptin leads
to the apoptosis of MCF7 cells within 48 h whereas MCF7-BCL-XL
cells remained viable and appeared morphologically healthy. These
observations were further confirmed by time-lapse studies. The
monitoring of apoptosis induced by HGV-Apoptin by flow
cytometry in both MCF7 and MCF7-BCL-XL cells from 24 to
96 h shows that over expression of the anti-apoptotic BCL-XL render
the cells resistance to HGV-Apoptin as they remain viable compared
to the parental clone (Figure 6A).
Since the protective effect of BCL-XL against HGV-Apoptin could
be cell type specific, we further tested the inhibitory activity of BCL-
A0
25
50
75
100
24h 48h 72h 96h 120h
Ce
ll 
su
rv
iv
al
 (%
)
Time post-electroporation (h)
Ctrl
GFP-HGV-APT-untreated
GFP-HGV-APT+QVD
B
25
50
75
100
24h 48h 72h 96h
Ce
ll 
su
rv
iv
al
 (%
)
Time post transfection GFP-HGV-APT (h) 
MCF7
MCF7+ QVD
MCF7/C3
MCF7/C3 + QVD
Figure 5. HGV-Apoptin mediated cell death is caspase-dependent.
A) Quantification of cell survival as percentage of PO-PRO/7AAD
double negative cells in the GFP-positive population from 24 to
120 h post-transfection. Jurkat cells were transfected either with
GFP-HGV-APT or with pEGFPC1 control plasmid and then either left
untreated or incubated with 25 μM of QVD-oph and then stained
with PO-PRO/7AAD. B) Quantification of cell survival as percentage
of PO-PRO/7AAD double negative cells in the GFP-positive
population from 24 to 96 h post-transfection. Wild-type caspase-
3 deficient MCF7 cells and MCF7 cells expressing caspase-3
(MCF7/C3) were transiently transfected either with GFP-HGV-APT
or with pEGFPC1 control plasmid and then either left untreated or
incubated with 25 μM of QVD-oph. Cells were then stained with
PO-PRO/7AAD and analyzed by flow cytometry.
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Apoptin via apoptosis monitoring by flow cytometry in both the
parental clone and Jurkat cells overexpressing BCL-XL. As shown in
Figure 6C, over-expression of BCL-XL also protected Jurkat cells
from HGV-Apoptin induced apoptosis. This data shows that HGV-
Apoptin induced apoptosis is regulated by the anti-apoptotic BCL-XL
independent of cell type.
Next, we have tested the role of the pro-apoptotic BAX and BAK in
HGV-Apoptin induced apoptosis using MEF cells that lack the
expression of BAX and BAK (MEF-BAX-BAK-/-). While MEF WT
cells were sensitive to the transient expression of HGV-Apoptin,
MEF-BAX-BAK-/- cells remained viable and appeared morphologi-
cally healthy (Figure 6E). The monitoring of apoptosis induced by
HGV-Apoptin by flow cytometry in both MEF-WT and MEF-BAX-
BAK-/- cells from 24 to 72 h post-transfection shows that the lack of
expression of the pro-apoptotic family members BAX and BAK
protected MEF cells from HGV-Apoptin induced cell death.To further expand the above observations, we have measured the
mitochondrial membrane potential of MCF7-WT, MCF7-BCL-XL
(Figure 6B), Jurkat-WT, Jurkat-BCL-XL (Figure 6D) MEF-WT, and
MEF-BAX-BAK-/- (Figure 6F) at 48 and 72 hours post transfection
with HGV-Apoptin expressing vector. The parental clones showed a
decrease in the mitochondrial potential while the BCL-XL-expressing
cells have maintained their mitochondrial membrane potential. Also,
MEF-BAX-BAK-/- cells failed to respond with the decrease of
mitochondrial membrane potential upon the expression of HGV-
Apoptin. Taking together, this data show that HGV-Apoptin
induced apoptosis is regulated by the BCL-2 family members, both
the pro- and the anti-apoptotic ones.
HGV-Apoptin Mediated Cell Death is Independent from p53
Signal and Induces the Cytoplasmic Translocation of Nur77
HGV-Apoptin activates the mitochondrial cell death pathway. p53
and Nur77 are the main molecules capable of transmitting the
apoptotic stimuli from nucleus to the cytoplasm. Thus we tested their
respective role in HGV-APT induced cell death.
First, we investigated the role of p53, the tumor suppressor protein.
p53 functions as a transcriptional regulator of multiple apoptotic
genes, also has a direct pro-apoptotic function in the mitochondria by
directly interacting with both the anti- and pro-apoptotic BCL-2
family members [15,34].
As shown in Figure 7A, lack of expression of p53 inHCT116 cells does
not prevent HGV-Apoptin from induction of apoptosis as both
HCT116 WT and their counterparts lacking p53 both were equally
sensitive to HGV-Apoptin expression. Hence, both cell-types show
apoptotic morphology in response to HGV-Apoptin expression (48 h
time-point). To get further insight in the role of p53 in HGV-Apoptin
induced apoptosis, we have performed a time course studies. We have
monitored apoptosis in HCT116-WT and their p53-deficient progeny
between 24 and 120 h post-transfection with HGV-Apoptin by laser-
scanning cytometry. Cells with a condensed chromatin were considered
apoptotic and quantified (Figure 7B). These experiments show that
HGV-Apoptin does not require p53 for induction of apoptosis.
Next, we tested the role of NUR77, an orphan nuclear receptor
and member of the steroid/thyroid receptor family, in HGV-Apoptin
triggered apoptosis. NUR77 is capable not only of transmitting the
apoptotic stimuli from the nucleus to the mitochondria [38], but also
can modulate apoptosis via activating the transcription of pro- and
anti-apoptotic genes [39]. Expression of HGV-Apoptin leads to the
translocation of NUR77 from nucleus to the cytoplasm in both
HCT116 (Figure 8A) and MCF7 cells (Figure 8B), indicating that
NUR77 is a signaling molecule transmitting apoptotic signal in
HGV-Apoptin pathway.
Discussion
The selective targeting of cancer cells has been a ‘holy grail’ of cancer
therapy. Since cancer cells are derived from our own healthy tissues,
the task seems very difficult. However, in the past two decades,
growing number of proteins have been discovered, that display
selective anti-cancer activity [40]. The protoplast of the group is
CAV-Apoptin, discovered in the mid-90s by Noteborn and
colleagues [41]. CAV-Apoptin causes apoptosis of cultured tumor-
igenic and transformed human cell lines but is harmless to normal
cells [19]. This cancer cell selective toxicity made CAV-Apoptin
among the most potential candidate for tumor cells selective therapy.
Recently, in 2011, the human homolog of the CAV-Apoptin has
been identified. The human gyrovirus-Apoptin (HGV-Apoptin) [23]
688 Human-Gyrovirus-apoptin action Chaabane et al. Neoplasia Vol. 16, No. 9, 2014displays the same differential behavior between normal and tumor
cells as its homolog. Recently published studies show that HGV-
Apoptin translocates to the nucleus of transformed cells while it
remains in the cytoplasm of normal cells, similarly to CAV-Apoptin.
Moreover, HGV-Apoptin also induces apoptosis in cancer cells while
leaving normal cells intact [25]. This prompted us to deeper the study
of cytotoxycity mechanism of HGV-Apoptin. Better understandingA
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HGV-Apoptin induced apoptosis. FADD and caspase-8 are the most
important upstream components of the CD95/Fas signaling pathway,
so using cells that overexpress a dominant negative form of FADD and
other molecular tools, we show that neither FADD nor caspase-8 areFigure 6. HGV-Apoptin induced apoptosis is regulated by the anti- a
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Apoptin, like its homolog CAV-Apoptin, kills cancer cells indepen-
dently from the CD95 system.
The mitochondrial intrinsic death pathway is ultimately activated
by a number of anti-cancer drugs and stress stimuli that cause the loss
of the mitochondrial membrane potential [47] and the release of a
number of pro-apoptotic molecules from the mitochondria. Among
others, released are cyt c and AIF [48,49]. Hence, we have checked
the mitochondrial alterations induced by HGV-Apoptin, also the
cellular localization of cyt c and AIF. We have observed that HGV-
Apoptin induces a decrease in the mitochondrial potential, and release
of both cyt c and AIF from the mitochondria.
Although caspase-independent forms of apoptosis have been
described [50], among them the nuclear translocation of AIF where
it induces apoptosis via DNA fragmentation, caspases play a crucial
role in apoptosis and are activated in both the extrinsic and intrinsic
pathways. Caspases are activated through the formation of large
protein complexes namely ‘death inducing signal complex’ (DISC)
within the extrinsic pathway or the apoptosome within the intrinsic
pathway [7]. Lack of expression of APAF1 (a major component of the
apoptosome), strongly delayed HGV-Apoptin induced apoptosis (up
to 96 h post-transfection).
Apoptosome is the molecular platform for caspase-9 activation.
Caspase-9 then activates down-stream caspases namely caspase-3 and
caspase-7 [51,52] leading to the execution of apoptosis (Figure 9). Soin order to investigate the requirement of caspase activity in HGV-
Apoptin induced apoptosis, we have used the broad-spectrum caspase
inhibitor QVD-oph that inhibits both up-stream and down-stream
caspases. QVD-oph delayed HGV-Apoptin induced cell death,
indicating that HGV-Apoptin induced apoptosis occurs in a caspase-
dependent manner. The inhibitory effect of QVD on HGV-Apoptin
induced cell death was not only observed in Jurkat T cells but also in
caspase-3 deficient MCF7 cells and its retransfected derivative MCF7/
C3, which were only protected from HGV-Apoptin induced cell death
in the presence of the caspase inhibitor. It should be noted that HGV-
Apoptin kills MCF7 cells that lack the expression of caspase-3, which
indicates that caspase-3 may be dispensable for HGV-Apoptin induced
cell death, and substituted by other down-stream caspases such as
caspase-6 and caspase-7. Moreover, the ectopic expression of caspase-3
in MCF7 cells renders them slightly more sensitive to HGV-Apoptin.
Thus, HGV-Apoptin requires caspase activity to kill its targets.
The mitochondrial pathway is modulated by the pro- and anti-
apoptotic BCL-2 family members [53]. In order to check the role of
the BCL-2 members in HGV-Apoptin induced cell death, we have
used MCF7 cells that overexpress the anti-apoptotic BCL-XL. Over-
expression of BCL-XL inhibits the pro-apoptotic molecules BAX and
BAK that in turn, inhibit MOMP and the release of pro-apoptotic
molecules from the mitochondria [54]. Over-expression of BCL-XL
protected MCF7 cells from HGV-Apoptin induced apoptosis.
Moreover, murine embryonic fibroblasts that lack the expression of
Bax/Bak
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BAkBAX
BCL-2
subfamily
Apoptosome
Caspase-9
Pro-caspase-9
APAF1
Caspase-3 Nucleus
Cyt. c AIF
MOMP
m
m
Nur77
Nur77
Nur77
Nur77
Nur77
Nur77
Nur77
Nur77
?
HGV-
Apoptin
HGV-
Apoptin
HGV-
Apoptin
HGV-
Apoptin
Apoptosis
ΔΨ
ΔΨ
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induced apoptosis compared to their parental clones. Thus, both pro-
and anti-apoptotic BCL-2 family members regulate HGV-Apoptin
induced cell death.
In conclusion, in this paper, we have given an insight into the
molecular mechanism of HGV-Apoptin induced cell death (Figure 9).
We show that HGV-Apoptin acts via the intrinsic mitochondrial
pathway in a caspase-dependent manner, and that its activity is
modulated by BCL-2 family members. Elucidating the molecular
mechanism of HGV-Apoptin's signaling pathway is of great
importance, and it may lead into the development of novel anticancer
strategy allowing for selective targeting of cancer cells. Comparative
study of HGV-Apoptin and CAV-Apoptin signaling pathways, may
lead to the discovery of new molecular targets uniquely available only
in cancer cells. HGV-Apoptin does not require p53 tumor suppressorsignaling whose inactivation is a frequent event in tumorigenesis [55],
and which leads to the resistance to available cancer therapies [56].
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